Yoo et al. demonstrated that replacing dysfunctional microglia with myeloid cells from the bloodstream via hematopoietic cell transplantation restored TREM2 function and improved memory in AD-like mice with TREM2 mutations (Yoo et al. 2023). The gene discussed is TREM2; the disease is Alzheimer disease.